FDA — authorised 28 January 2016
- Application: NDA208261
- Marketing authorisation holder: MSD SUB MERCK
- Status: supplemented
FDA authorised Zepatier on 28 January 2016
Yes. FDA authorised it on 28 January 2016; FDA has authorised it.
MSD SUB MERCK holds the US marketing authorisation.